Market Research Report
Global Liquid Biopsy Market Insights and Forecast to 2028
|Global Liquid Biopsy Market Insights and Forecast to 2028|
Published: January 18, 2022
Content info: 111 Pages
Delivery time: 2-3 business days
Increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D are some of the key factors driving the growth of the market.
Market Analysis and Insights: Global Liquid Biopsy Market
Due to the COVID-19 pandemic, the global Liquid Biopsy market size is estimated to be worth US$ 1009.2 million in 2022 and is forecast to a readjusted size of US$ 2822.9 million by 2028 with a CAGR of 18.7% during the review period. Fully considering the economic change by this health crisis, Test Suite accounting for % of the Liquid Biopsy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Food Laboratory segment is altered to an % CAGR throughout this forecast period.
The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.
Global Liquid Biopsy Scope and Segment
Liquid Biopsy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application